Your browser doesn't support javascript.
loading
IMB-XMA0038, a new inhibitor targeting aspartate-semialdehyde dehydrogenase of Mycobacterium tuberculosis.
Wang, Xiao; Yang, Ruifang; Liu, Sihan; Guan, Yan; Xiao, Chunling; Li, Chuanyou; Meng, Jianzhou; Pang, Yu; Liu, Yishuang.
Afiliación
  • Wang X; National Laboratory for Screening New Microbial Drugs, Institute of Medicinal Biotechnology, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, People's Republic of China.
  • Yang R; Department of Bacteriology and Immunology, Beijing Key Laboratory on Drug-Resistant Tuberculosis Research, Beijing Tuberculosis and Thoracic Tumor Research Institute/Beijing Chest Hospital, Capital Medical University, Beijing, People's Republic of China.
  • Liu S; National Laboratory for Screening New Microbial Drugs, Institute of Medicinal Biotechnology, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, People's Republic of China.
  • Guan Y; National Laboratory for Screening New Microbial Drugs, Institute of Medicinal Biotechnology, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, People's Republic of China.
  • Xiao C; National Laboratory for Screening New Microbial Drugs, Institute of Medicinal Biotechnology, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, People's Republic of China.
  • Li C; Department of Bacteriology and Immunology, Beijing Key Laboratory on Drug-Resistant Tuberculosis Research, Beijing Tuberculosis and Thoracic Tumor Research Institute/Beijing Chest Hospital, Capital Medical University, Beijing, People's Republic of China.
  • Meng J; National Laboratory for Screening New Microbial Drugs, Institute of Medicinal Biotechnology, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, People's Republic of China.
  • Pang Y; Department of Bacteriology and Immunology, Beijing Key Laboratory on Drug-Resistant Tuberculosis Research, Beijing Tuberculosis and Thoracic Tumor Research Institute/Beijing Chest Hospital, Capital Medical University, Beijing, People's Republic of China.
  • Liu Y; National Laboratory for Screening New Microbial Drugs, Institute of Medicinal Biotechnology, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, People's Republic of China.
Emerg Microbes Infect ; 10(1): 2291-2299, 2021 Dec.
Article en En | MEDLINE | ID: mdl-34779708
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Aspartato-Semialdehído Deshidrogenasa / Proteínas Bacterianas / Tuberculosis / Inhibidores Enzimáticos / Mycobacterium tuberculosis / Antituberculosos Idioma: En Revista: Emerg Microbes Infect Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Aspartato-Semialdehído Deshidrogenasa / Proteínas Bacterianas / Tuberculosis / Inhibidores Enzimáticos / Mycobacterium tuberculosis / Antituberculosos Idioma: En Revista: Emerg Microbes Infect Año: 2021 Tipo del documento: Article